On the other hand, patients with a high BMI have more adipose tissue and, consequently, secrete greater amounts of adiponectin, IL-6, and tumor necrosis factor, resulting in metabolic disorders and a decrease in skeletal muscle mass, making these patients more prone to frailty [29,30]. Here, ADIPOQ is linked to Other metabolic disease.